PLoS ONE · 2013 · 11 citations · 16 references
ImmunologyPathologyPotential Cancer BiomarkersCancer BiologyTumor BiologyProteomic TechnologyTumor ImmunityAnti-phospho-eef2 AntibodiesProteomicsRadiation OncologyCancer ResearchPotential TaaTranslational ProteomicsCell BiologyTumor MicroenvironmentNew TaaHypoxia UpstreamCancer ImmunosurveillanceHypoxia IntegrationMedicine
The expression by tumor cells of proteins with aberrant structure, expression or distribution accounts for the development of a humoral immune response. Autoantibodies (aAb) directed against tumor-associated antigens (TAA) may thus be particularly relevant for early detection of cancer. Serological proteome analysis (SERPA) aims to identify such circulating aAb through the immunoblotting of 2D-separated tumor cell proteins with cancer patient serum and the consecutive MS identification of proteins in reactive spots. This method has the advantage to use post-translationally modified proteins as a source of potential TAA. Here, we applied this strategy by using colorectal tumor cells pre-exposed to hypoxia in order to promote the expression of a pattern of TAA more likely to represent in vivo conditions. We used two human HCT116 and HT29 colorectal cancer cell lines exposed for 48 hours to 1% O2. Spots positive after immunoblotting of 2D-separated lysates of hypoxic cells with the sera of tumor-bearing mice, were collected and analysed by MS for protein identification. Among the hypoxia-specific immunogenic proteins, we identified a phosphorylated form of eukaryotic translation elongation factor 2 (phospho-Thr56 eEF2). We confirmed the increased phosphorylation of this protein in hypoxic colorectal tumor cells as well as in mouse tumors. Using a specific immunoassay, we could detect the presence of corresponding anti-phospho-Thr56 eEF2 aAb in the serum of tumor-bearing mice (vs healthy mice). We further documented that the detection of these aAb preceded the detection of a palpable tumor mass in mice and validated the presence of anti-phospho-Thr56 eEF2 aAb in the serum of patients with adenomatous polyps and colorectal carcinoma. In conclusion, this study validates a phosphorylated form of eEF2 as a new TAA and more generally, provides evidence that integrating hypoxia upstream of SERPA offers a more relevant repertoire of TAA able to unmask the presence of circulating aAb.
16
Least squares quantization in PCM
Sheelagh Lloyd · IEEE Transactions on Information Theory · 1982 · 15.1K citations · Full text
Drug delivery with carbon nanotubes for in vivo cancer treatment
Zhuang Liu, Kai Chen, Corrine R. Davis et al. · PubMed · 2008 · 2.3K citations · Full text
Sandrine Horman, Gareth J. Browne, U. Krause et al. · Current Biology · 2002 · 448 citations · Full text
Elongation Factor 2, Developmental Biology, Signal Transduction +9